Drug Profile
Choroid plexus cell replacement therapy - Living Cell Technologies
Alternative Names: Neurological disorders cell therapy - Living Cell Technologies; NeurotrophinCell; NTCELLLatest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator Living Cell Technologies
- Developer Auckland UniServices; Living Cell Technologies; University of Auckland
- Class Antidementias; Antiparkinsonians; Cell therapies; Eye disorder therapies; Neuroprotectants
- Mechanism of Action Cell replacements; Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Parkinson's disease
- No development reported Alzheimer's disease; Hearing loss; Huntington's disease; Osteoarthritis; Osteoporosis; Retinal disorders; Spinal cord injuries; Stroke; Wounds
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for research development in Alzheimer's-disease in New Zealand
- 28 Jan 2020 No recent reports of development identified for preclinical development in Hearing loss in New Zealand (Intrastriatal, Injection)
- 28 Jan 2020 No recent reports of development identified for preclinical development in Huntington's-disease in New Zealand (Intrastriatal, Injection)